Inventor · disambiguated record
Yuan Liu
Also filed as: LIU YUAN · LIU YUAN-CHIN
64 granted patents·34 pending applications·736 citations·filing 2001–2025
99Inventor score
Files withARAXES PHARMA LLC39MEDIATEK INC14MERCK SHARP & DOHME10KUMQUAT BIOSCIENCES INC4GRITSCIENCE BIOPHARMACEUTICALS CO LTD3
Top patents by PatentIndex Score
98 records- 0198US10144724B2Substituted quinazoline compounds and methods of use thereofARAXES PHARMA LLC·Filed 2016·Granted Dec 4, 2018·44 cites·42 claims
- 0297US10745385B2Covalent inhibitors of KRASARAXES PHARMA LLC·Filed 2018·Granted Aug 18, 2020·17 cites·54 claims
- 0397US10377743B2Inhibitors of RAS and methods of use thereofARAXES PHARMA LLC·Filed 2017·Granted Aug 13, 2019·29 cites·31 claims
- 0497US10370386B2Substituted quinolines as inhibitors of KRAS G12CARAXES PHARMA LLC·Filed 2017·Granted Aug 6, 2019·33 cites·30 claims
- 0597US10351550B2Substituted quinazoline compounds and methods of use thereofARAXES PHARMA LLC·Filed 2018·Granted Jul 16, 2019·27 cites·32 claims
- 0697US10246424B2Substituted quinazoline compounds and methods of use thereofARAXES PHARMA LLC·Filed 2016·Granted Apr 2, 2019·36 cites·90 claims
- 0797US9988357B2Methods for preparation of quinazoline derivativesARAXES PHARMA LLC·Filed 2016·Granted Jun 5, 2018·38 cites·32 claims
- 0897US9840516B2Substituted quinazolines as inhibitors of KRAS G12CARAXES PHARMA LLC·Filed 2014·Granted Dec 12, 2017·73 cites·33 claims
- 0996US10927125B2Substituted cinnolines as inhibitors of KRAS G12CARAXES PHARMA LLC·Filed 2019·Granted Feb 23, 2021·11 cites·29 claims
- 1096US10829458B2Substituted quinazoline compounds and methods of use thereofARAXES PHARMA LLC·Filed 2019·Granted Nov 10, 2020·13 cites·29 claims
- 1196US10723738B2Inhibitors of KRAS G12C mutant proteinsARAXES PHARMA LLC·Filed 2019·Granted Jul 28, 2020·15 cites·22 claims
- 1296US10689356B2Inhibitors of KRAS G12C mutant proteinsARAXES PHARMA LLC·Filed 2016·Granted Jun 23, 2020·16 cites·15 claims
- 1396US10414757B22-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereofARAXES PHARMA LLC·Filed 2016·Granted Sep 17, 2019·33 cites·49 claims
- 1496US10280172B2Inhibitors of KRAS G12C mutant proteinsARAXES PHARMA LLC·Filed 2017·Granted May 7, 2019·34 cites·19 claims
- 1595US10736897B2Compounds and methods of use thereof for treatment of cancerARAXES PHARMA LLC·Filed 2018·Granted Aug 11, 2020·28 cites·15 claims
- 1695US10515939B2Wafer-level package having multiple dies arranged in side-by-side fashion and associated yield improvement methodMEDIATEK INC·Filed 2016·Granted Dec 24, 2019·13 cites·6 claims
- 1795US10428064B2Fused-tricyclic inhibitors of KRAS and methods of use thereofARAXES PHARMA LLC·Filed 2016·Granted Oct 1, 2019·27 cites·28 claims
- 1895US7393930B2Modified protein adhesives and lignocellulosic composites made from the adhesivesOREGON STATE·Filed 2006·Granted Jul 1, 2008·31 cites·35 claims
- 1994US11878985B2Substituted quinazolines as inhibitors of KRAS G12CARAXES PHARMA LLC·Filed 2020·Granted Jan 23, 2024·2 cites·43 claims
- 2094US11377441B2Covalent inhibitors of KRASARAXES PHARMA LLC·Filed 2020·Granted Jul 5, 2022·3 cites·28 claims
- 2194US11021470B22-substituted quinazoline compounds comprising a substituted heterocyclic group and methods of use thereofARAXES PHARMA LLC·Filed 2019·Granted Jun 1, 2021·8 cites·21 claims
- 2293US11059819B2Fused hetero-hetero bicyclic compounds and methods of use thereofARAXES PHARMA LLC·Filed 2018·Granted Jul 13, 2021·8 cites·20 claims
- 2393US10975071B2Inhibitors of KRAS G12C mutant proteinsARAXES PHARMA LLC·Filed 2016·Granted Apr 13, 2021·9 cites·20 claims
- 2493US7060798B2Modified protein adhesives and lignocellulosic composites made from the adhesivesOREGON STATE·Filed 2003·Granted Jun 13, 2006·62 cites·43 claims
- 2592US10221146B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Mar 5, 2019·6 cites·18 claims
- 2692US9809561B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·8 cites·16 claims
- 2792US9663502B22-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted May 30, 2017·12 cites·26 claims
- 2891US9783511B2Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Oct 10, 2017·9 cites·21 claims
- 2989US11387176B2Semiconductor package structureMEDIATEK INC·Filed 2020·Granted Jul 12, 2022·2 cites·21 claims
- 3089US11279689B21-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancerARAXES PHARMA LLC·Filed 2018·Granted Mar 22, 2022·4 cites·13 claims
- 3189US11136308B2Substituted quinazoline and quinazolinone compounds and methods of use thereofARAXES PHARMA LLC·Filed 2018·Granted Oct 5, 2021·5 cites·26 claims
- 3288US11274093B2Fused bicyclic benzoheteroaromatic compounds and methods of use thereofARAXES PHARMA LLC·Filed 2018·Granted Mar 15, 2022·4 cites·16 claims
- 3388US2024352028A1Substituted quinazolines as inhibitors of kras g12cARAXES PHARMA LLC·Filed 2024·Application pending·0 cites
- 3487US11358959B2Benzothiophene and benzothiazole compounds and methods of use thereofARAXES PHARMA LLC·Filed 2018·Granted Jun 14, 2022·4 cites·20 claims
- 3586US9576367B2Object detection method and deviceYOU GANMEI·Filed 2015·Granted Feb 21, 2017·7 cites·13 claims
- 3686US8796310B2Amino-pyridine-containing spleen tyrosine kinase (SYK) inhibitorsROMEO ERIC THOMAS·Filed 2012·Granted Aug 5, 2014·16 cites·38 claims
- 3784US10037293B2Wafer-level package having asynchronous FIFO buffer used to deal with data transfer between different dies and associated methodMEDIATEK INC·Filed 2016·Granted Jul 31, 2018·4 cites·19 claims
- 3884US2025154133A1Covalent inhibitors of krasARAXES PHARMA LLC·Filed 2024·Application pending·0 cites
- 3984US2024043441A1Inhibitors of kras g12cARAXES PHARMA LLC·Filed 2023·Application pending·0 cites
- 4084US2023303586A1Inhibitors of kras g12cARAXES PHARMA LLC·Filed 2023·Application pending·0 cites
- 4183US10261928B2Wafer-level package having one die with its clock source shared by multiple dies and associated clock generating methodNEPHOS HEFEI CO LTD·Filed 2018·Granted Apr 16, 2019·4 cites·14 claims
- 4281US12234244B2Substituted piperazines as inhibitors of KRAS G12CARAXES PHARMA LLC·Filed 2022·Granted Feb 25, 2025·0 cites·12 claims
- 4380USRE50490ESubstituted quinazoline compounds and methods of use thereofARAXES PHARMA LLC·Filed 2022·Granted Jul 15, 2025·0 cites·29 claims
- 4479US7804327B2Level shiftersMEDIATEK INC·Filed 2007·Granted Sep 28, 2010·10 cites·19 claims
- 4577US11639346B2Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRASARAXES PHARMA LLC·Filed 2018·Granted May 2, 2023·2 cites·25 claims
- 4677US7821890B2Apparatus for writing a data to an optical storage media and servo control unit and laser diode driver unit thereofMEDIATEK INC·Filed 2005·Granted Oct 26, 2010·3 cites·24 claims
- 4776US2023203018A1Covalent inhibitors of krasARAXES PHARMA LLC·Filed 2022·Application pending·0 cites
- 4874US2025136609A1Heterocyclic spiro compounds and methods of use thereof for the treatment of cancerARAXES PHARMA LLC·Filed 2024·Application pending·0 cites
- 4972US12424531B2Semiconductor package structureMEDIATEK INC·Filed 2024·Granted Sep 23, 2025·0 cites·20 claims
- 5072US12002742B2Semiconductor package structureMEDIATEK INC·Filed 2022·Granted Jun 4, 2024·0 cites·15 claims
Showing the top 50 of 98 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Yuan Liu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →